Alternatively to the invasive SoC analyses carried out in locally restricted tumour tissue specimens obtained by surgery or throughout a biopsy at the time of the diagnosis of the disease, the evaluation of the RAS mutational status using plasmatic ctDNA isolated from peripheral blood allows a spatial-temporal view of the tumour [32]. Here, UBXN11 is linked to neoplasm.